Royal Bhanyan Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.10 Cr
as on 22-05-2024
- Paid Up Capital ₹ 6.10 Cr
as on 22-05-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.08%
(FY 2017)
- Profit 26470.88%
(FY 2017)
- Ebitda 24.92%
(FY 2017)
- Net Worth 0.78%
(FY 2017)
- Total Assets 0.17%
(FY 2017)
About Royal Bhanyan Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.10 Cr and a paid-up capital of Rs 6.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ponnuswamy Manohar and Manohar Rathi serve as directors at the Company.
- CIN/LLPIN
U01119TN2005PTC055941
- Company No.
055941
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2005
- Date of AGM
30 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Royal Bhanyan Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ponnuswamy Manohar  | Managing Director | 11-Apr-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manohar Rathi | Director | 11-Apr-2005 | Current |
Financial Performance and Corporate Structure Insights of Royal Bhanyan Biotech.
Royal Bhanyan Biotech Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 25.08% increase. The company also saw a substantial improvement in profitability, with a 26470.88% increase in profit. The company's net worth moved up by a moderate rise of 0.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Royal Bhanyan Biotech?
In 2017, Royal Bhanyan Biotech had a promoter holding of 98.62% and a public holding of 1.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krish Media Works Private LimitedActive 25 years 1 monthPonnuswamy Manohar and Manohar Rathi are mutual person
- Royal Bhanyan Financial Services Private LimitedActive 13 years 9 months
Ponnuswamy Manohar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Royal Bhanyan Biotech?
Unlock and access historical data on people associated with Royal Bhanyan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Royal Bhanyan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Bhanyan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
